Filing Details
- Accession Number:
- 0001209191-15-049571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-03 16:21:00
- Reporting Period:
- 2015-06-01
- Filing Date:
- 2015-06-03
- Accepted Time:
- 2015-06-03 16:21:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289409 | Patrick Miles | 7475 Lusk Blvd. San Diego CA 92121 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-01 | 29,081 | $34.82 | 121,569 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-01 | 24,887 | $49.85 | 96,682 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-06-02 | 4,194 | $49.47 | 92,488 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2015-06-01 | 29,081 | $0.00 | 29,081 | $34.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-01-02 | No | 4 | M | Direct |
Footnotes
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 7, 2014, which is intended to comply with Rule 10b5-1.
- The option, representing a right to purchase a total of 147,129 shares, became exercisable as follows: 25% of the shares vested on January 2, 2010; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 2, 2013, subject to continued employment through each vesting period.
Billionaire Hedge Funds
